Navigation Links
Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report
Date:11/3/2008

ALBUQUERQUE, N.M., Nov. 3 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com), a development stage medical diagnostics company, announced today that BUYINS.NET, http://www.buyins.net, is initiating coverage of Biomoda after releasing the latest short sale data to October 2008. From November 2006 to October 2008 approximately 13.6 million total aggregate shares of BMOD have traded for a total dollar value of nearly $3.6 million. The total aggregate number of shares shorted in this time period is approximately 1 million shares. The BMOD SqueezeTrigger price of $0.27 is the volume weighted average short price of all short selling in BMOD. The first of several short squeezes is expected to begin when shares of BMOD close above $0.05, where approximately 16,000 shares have been shorted. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

Month Total Vol. Short Vol. Avg. Price Short $ Value

November '06 1,350 104 $3.50 $364

December 12,500 963 $2.90 $2,791

January '07 476,123 36,661 $1.77 $64,982

February 306,044 23,565 $0.96 $22,682

March 381,010 29,338 $0.75 $22,077

April 442,725 34,090 $0.65 $21,988

May 1,092,498 84,122 $0.49 $41,430

June 1,750,488 134,788 $0.23 $31,001

July 2,658,260 204,686 $0.12 $23,539

August 1,565,381 120,534 $0.06 $7,774

September 423,743 32,628 $0.09 $3,018

October 757,954 58,362 $0.13 $7,663

November 703,878 54,199 $0.20 $10,840

December 291,895 22,476 $0.21 $4,608

January '08 233,309 17,965 $0.15 $2,671

February 195,609 15,062 $0.11 $1,627

March 762,900 58,743 $0.07 $4,042

April 299,200 23,038 $0.06 $1,451

May 326,100 25,110 $0.07 $1,665

June 361,240 27,815 $0.06 $1,766

July 164,700 12,682 $0.06 $774

August 178,932 13,778 $0.06 $861

September 179,350 13,810 $0.05 $621

October 31,409 2,418 $0.05 $118

Total: 13,596,598 1,046,938 $0.27 $280,353

* short volume is approximated using a proprietary algorithm.

** average short price is calculated using a volume weighted average

short price.

*** short volume is the total short trade volume and does not account for

covers.

Market Maker Friction Factor is shown in the chart below:

Date Change % BuyVol Buy% SellVol Sell% NetVol Friction

10/29/2008 -0.02 -40.00% 0 0.00% 500 100.00% -500 -250

10/28/2008 0 0.00% 0 0.00% 0 0.00% 0 0

10/27/2008 -0.01 -16.67% 0 0.00% 5,000 100.00 -5,000 -5000

10/24/2008 0 0.00% 0 0.00% 0 0.00% 0 0

Analysis of the Friction Factor chart above shows that in the 4 trading days preceding this report that market makers have been making a normal market in shares of BMOD. The Friction Factor displays how many more shares of buying than selling are required to move BMOD higher by one cent or how many more shares of selling than buying moves BMOD lower by 1 cent. The Friction Factor is relatively low at this time so shares can be expected to move quickly should shares of BMOD close above the first SqueezeTrigger levels between $.05 and $.07. Buyins.net will continue its daily market surveillance of BMOD to ensure a fair and orderly market is being made in its shares.

The chart below shows the broker dealers acting as market makers in shares of BMOD.

% of Total

Rank Market Maker Volume Jan - Sep 2008 Volume

1 Knight Equity Markets 1,106,582 41

2 UBS Securities 502,143 18

3 Domestic Securities 257,200 9

4 E*Trade Capital Markets 182,665 6

5 Hudson Securities 154,800 5

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Biomoda, Inc. has paid $995 per month to purchase data for information provided in this six monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.


'/>"/>
SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
2. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
3. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
4. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
5. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
6. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
7. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
8. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
9. Vista Partners Updates Coverage; Maintains $3.20 Target Price
10. Neptune Technologies decided not to re-price options
11. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , February 11, 2016 ... Corporation ("PositiveID" or "Company") (OTCQB: PSID), a life ... today that its Thermomedics subsidiary, which markets the ... its growth plan in January 2016, including entering ... increasing sequential monthly sales growth, and establishing several ...
(Date:2/10/2016)... - BioAmber Inc. (NYSE: BIOA ), a leader ... & Co. Ltd., its partner in the ... an additional CDN$25 million in the joint venture for ... to 40%.  Mitsui will also play a stronger role ... Sarnia , providing dedicated resources alongside BioAmber,s ...
(Date:2/10/2016)... York, New York (PRWEB) , ... ... ... Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined the Human ... and immunotherapies for infectious diseases and cancer. , The Human Vaccines ...
(Date:2/10/2016)... ... February 10, 2016 , ... HOLLOWAY ... of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor Exhibition on Thursday, ... more than 100 tables for its annual event, which will run from 3:00 ...
Breaking Biology Technology:
(Date:2/10/2016)... PUNE, India , February 10, 2016 ... --> According to 2016 iris ... fingerprint identification iris recognition is more widely ... are available with both fingerprint and iris ... allows the user to avoid purchasing two ...
(Date:2/4/2016)... , Feb. 4, 2016 The field ... one of the most popular hubs of the ... and other huge studies of human microbiota, have ... few years, the microbiome space has literally exploded ... research. This report focuses on biomedical aspects ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
Breaking Biology News(10 mins):